DiagnaMed Holdings Corp. (CSE: DMED) (OTCQB: DGNMF) is a generative artificial intelligence healthcare company focused on developing and commercializing CERVAI™, a proprietary brain health AI platform. A world first, CERVAI™ consists of a Brain Age Estimation and Brain Health Assessment tool. The Brain Age Estimation tool includes a novel electroencephalogram headset and machine-learning model. It integrates proprietary software into unified and standardized data recording protocols. The Brain Health Assessment tool generates clinician-observed measures and a brain health score. These combined allow users to be proactive in achieving their brain health goals.
Intellectual Property
Fundraising
Founders Fast Track is 6 week mentorship program that provides your startup with access to industry expertise, resources, networking opportunities, and skills to help you secure investment capital.
Applications are open until April 13, 2025.
Innovation Factory’s Synapse Competition is Ontario’s premier life science pitch competition, dedicated to fostering innovation in the life science sector.
March 26, 2025 | 4:00pm – 8:00pm EDT
